Pharmaceutical Technology3 天
ONO-4915 by Ono Pharmaceutical for Autoimmune Disorders: Likelihood of Approval
ONO-4915 is under clinical development by Ono Pharmaceutical and currently in Phase I for Autoimmune Disorders.